Relay Therapeutics Inc
(RLAY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -94,239 | -290,509 | -223,006 | -138,834 | -62,046 |
| Depreciation Amortization | -820 | 5,312 | 4,531 | 3,158 | 1,656 |
| Accounts receivable | 20 | 97 | 162 | 115 | 134 |
| Accounts payable and accrued liabilities | 1,400 | N/A | 22 | -4,611 | -1,223 |
| Other Working Capital | 7,414 | 11,246 | 4,876 | 5,203 | 2,357 |
| Other Operating Activity | 19,095 | 44,364 | 41,004 | 28,703 | 9,949 |
| Operating Cash Flow | $-67,130 | $-229,490 | $-172,411 | $-106,266 | $-49,173 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 175,044 | 355,736 | 172,715 | 87,600 | 18,100 |
| PPE Investments | -1,915 | -9,062 | -6,746 | -4,651 | -2,794 |
| Purchase Of Investment | -97,815 | -535,419 | -207,778 | -151,945 | -127,690 |
| Investing Cash Flow | $75,314 | $-188,745 | $-41,809 | $-68,996 | $-112,384 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,297 | 289,910 | 288,744 | 2,879 | 883 |
| Financing Cash Flow | $1,297 | $289,910 | $288,744 | $2,879 | $883 |
| Beginning Cash Position | 154,372 | 282,697 | 282,697 | 282,697 | 282,697 |
| End Cash Position | 163,853 | 154,372 | 357,221 | 110,314 | 122,023 |
| Net Cash Flow | $9,481 | $-128,325 | $74,524 | $-172,383 | $-160,674 |
| Free Cash Flow | |||||
| Operating Cash Flow | -67,130 | -229,490 | -172,411 | -106,266 | -49,173 |
| Capital Expenditure | -1,915 | -9,062 | -6,746 | -4,651 | -2,794 |
| Free Cash Flow | -69,045 | -238,552 | -179,157 | -110,917 | -51,967 |